Funded Startups in Burlington
The 50 most recent funded rounds across Burlington locations span Burlington, Massachusetts; Burlington, Vermont; Burlington, Ontario; and Burlington, Wash…
The 50 most recent funded rounds across Burlington locations span Burlington, Massachusetts; Burlington, Vermont; Burlington, Ontario; and Burlington, Washington — with Burlington, MA accounting for the largest share of disclosed capital. The three biggest rounds in the dataset are LeMaitre Vascular's $150M raise (December 2024), HostPapa's $130M (June 2025, Burlington Ontario), and SalioGen Therapeutics' $115M Series B (January 2022). Butterfly Network ($76M, January 2025) and Lightforce Orthodontics' $80M Series D (August 2023) round out the top five.
Burlington, MA functions as a clear biotech and life sciences corridor — Lifordi Immunotherapeutics ($42M venture, November 2025), CoreMap ($20M Series B, February 2022), and Bone Biologics ($5M, June 2025) are among its recent raises. Burlington, VT skews toward energy, sustainability, and community sectors, with rounds for Encore Renewable Energy, Verde Technologies, and wasted* (an $8M seed, January 2023). Round types in the data range from sub-$1M community grants and early seed checks to post-IPO debt instruments, reflecting a heterogeneous funding ecosystem spread across four distinct Burlington geographies.
Most recent rounds
50 shownRelated listings
Frequently asked
What are the largest disclosed rounds in the Burlington data?
LeMaitre Vascular leads with $150M (December 2024, Burlington MA), followed by HostPapa at $130M (June 2025, Burlington Ontario) and SalioGen Therapeutics at $115M Series B (January 2022, Burlington MA). Lightforce Orthodontics raised an $80M Series D in August 2023, and Butterfly Network closed a $76M round in January 2025.
Which Burlington location accounts for the most funding activity in this dataset?
Burlington, Massachusetts dominates, with companies spanning biotechnology (Lifordi Immunotherapeutics, SalioGen, CoreMap), medical devices (LeMaitre Vascular, Lightforce Orthodontics), and IT (MatrixSpace, Signiant, ZSuite Technologies). Burlington, Vermont is the second most represented location, concentrated in energy, sustainability, and community organizations.
What sectors see the most deal flow in Burlington, MA?
Biotechnology and life sciences account for the highest concentration — Lifordi Immunotherapeutics, SQ Innovation, Bone Biologics, CoreMap, and SalioGen Therapeutics have all raised rounds there. Medical devices (LeMaitre Vascular, Lightforce Orthodontics) and SaaS or data infrastructure (MatrixSpace, Signiant, Sotero) also appear multiple times.
Are there post-IPO or private equity rounds mixed into Burlington's recent activity?
Yes. Desktop Metal raised $100M in post-IPO debt in May 2022, and Patriot One Technologies closed a $10M post-IPO equity round in March 2022, both indicating publicly traded companies returning to capital markets. Acoustic and Tempo both took private equity rounds in October 2022, though amounts were undisclosed.
How current is the Burlington funding activity in this view?
The most recent round is Lifordi Immunotherapeutics' $42M venture raise on November 19, 2025, followed by MatrixSpace's $20M Series B on October 16, 2025, and SQ Innovation's undisclosed Series B on October 9, 2025. The 50-row view extends back to January 2022.
What does early-stage activity look like across Burlington locations?
Seed rounds include wasted* ($8M, January 2023, Burlington VT), Sotero ($8M, July 2022, Burlington MA), and OhMD ($100K, February 2022, Burlington VT). Series A closes include Superplastic ($20M, February 2023), 10Beauty ($17M, February 2024), ZSuite Technologies ($11M, August 2022), and SiPhox Health (undisclosed, March 2025), all in Burlington MA or VT.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.